Z. Ş. TEKSİN Et Al. , "AT1002 Tight Junction Modulator Synthetic Peptide as Enhancers for Biovailability of Cyclosporin A via Intranasal Dosing," AAPS Annual Meeting , Texas, United States Of America, 2006
TEKSİN, Z. Ş. Et Al. 2006. AT1002 Tight Junction Modulator Synthetic Peptide as Enhancers for Biovailability of Cyclosporin A via Intranasal Dosing. AAPS Annual Meeting , (Texas, United States Of America).
TEKSİN, Z. Ş., SONG, K., FASANO, A., & EDDINGTON, N., (2006). AT1002 Tight Junction Modulator Synthetic Peptide as Enhancers for Biovailability of Cyclosporin A via Intranasal Dosing . AAPS Annual Meeting, Texas, United States Of America
TEKSİN, ZEYNEP Et Al. "AT1002 Tight Junction Modulator Synthetic Peptide as Enhancers for Biovailability of Cyclosporin A via Intranasal Dosing," AAPS Annual Meeting, Texas, United States Of America, 2006
TEKSİN, ZEYNEP Ş. Et Al. "AT1002 Tight Junction Modulator Synthetic Peptide as Enhancers for Biovailability of Cyclosporin A via Intranasal Dosing." AAPS Annual Meeting , Texas, United States Of America, 2006
TEKSİN, Z. Ş. Et Al. (2006) . "AT1002 Tight Junction Modulator Synthetic Peptide as Enhancers for Biovailability of Cyclosporin A via Intranasal Dosing." AAPS Annual Meeting , Texas, United States Of America.
@conferencepaper{conferencepaper, author={ZEYNEP ŞAFAK TEKSİN Et Al. }, title={AT1002 Tight Junction Modulator Synthetic Peptide as Enhancers for Biovailability of Cyclosporin A via Intranasal Dosing}, congress name={AAPS Annual Meeting}, city={Texas}, country={United States Of America}, year={2006}}